World Journal of Surgery

, Volume 31, Issue 9, pp 1872–1882

Reversal of Diabetes in Mice by Intrahepatic Injection of Bone-derived GFP-murine Mesenchymal Stem Cells Infected with the Recombinant Retrovirus-carrying Human Insulin Gene

  • Jian Xu
  • Yuhua Lu
  • Fei Ding
  • Xi Zhan
  • Mingyan Zhu
  • Zhiwei Wang
Article

Abstract

Background

The objective of this study was to assess the effect of intrahepatic injection of bone-derived green fluorescent protein (GFP)-transgenic murine mesenchymal stem cells (GFP-mMSCs) containing the human insulin(ins) gene in streptozotocin-induced diabetic mice.

Methods

GFP-mMSCs were isolated from the bone marrow of GFP transgenic mice, expanded, and transfected with a recombinant retrovirus MSCV carrying the human insulin gene. C57BL/6J mice were made diabetic by an intraperitoneal administration of 160 mg/kg streptozotocin (STZ), followed by intrahepatic injection of transfected GFP-mMSCs. The variations in body weight and the blood glucose and serum insulin levels were determined after cell transplantation. GFP-mMSCs survival and human insulin expression in liver tissues were examined by fluorescent microscopy and immunohistochemistry.

Results

The body weight in diabetic mice that received GFP-mMSCs harboring the human insulin gene was increased by 6% within 6 weeks after treatment, and the average blood glucose levels in these animals were 10.40 ± 2.80 mmol/l (day 7) and 6.50 ± 0.89 mmol/l (day 42), respectively, while the average values of blood glucose in diabetic animals without treatment were 26.80 ± 2.49 mmol/l (day 7) and 25.40 ± 4.10 mmol/l (day 42), showing a significant difference (p < 0.05). Moreover, secretion of human insulin of GFP-mMSCs in serum and animal liver was detected by radioimmunoassay (RIA) and immunohistochemistry (IHC).

Conclusions

Experimental diabetes could be relieved effectively for up to 6 weeks by intrahepatic transplantation of murine mesenchymal stem cells expressing human insulin. This study implies a novel approach of gene therapy for type I diabetes.

References

  1. 1.
    Hornum L, Markholst H (2004) New autoimmune genes and the pathogenesis of type 1 diabetes. Curr Diab Rep 4:135–142PubMedCrossRefGoogle Scholar
  2. 2.
    Roep BO (2003) The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46:305–321PubMedGoogle Scholar
  3. 3.
    Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. Can Med Assoc J 175:165–170CrossRefGoogle Scholar
  4. 4.
    Rother KI, Harlan DM (2004) Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 114:877–883PubMedCrossRefGoogle Scholar
  5. 5.
    Lakey JR, Mirbolooki M, Shapiro AM (2006) Current status of clinical islet cell transplantation. Methods Mol Biol 333:47–104PubMedGoogle Scholar
  6. 6.
    Abai AM, Hobart PM, Barnhart KM (1999) Insulin delivery with plasmid DNA. Hum Gene Ther 10:2637–2649PubMedCrossRefGoogle Scholar
  7. 7.
    Goldfine ID, German MS, Tseng HC, et al. (1997) The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol 15:1378–1382PubMedCrossRefGoogle Scholar
  8. 8.
    Mitanchez D, Chen R, Massias JF, et al. (1998) Regulated expression of mature human insulin in the liver of transgenic mice. FEBS Lett 421:285–289PubMedCrossRefGoogle Scholar
  9. 9.
    Valera A, Fillat C, Costa C, et al. (1994) Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J 8:440–447PubMedGoogle Scholar
  10. 10.
    Wu L, Nicholson W, Wu CY, et al. (2003) Engineering physiologically regulated insulin secretion in non-beta cells by expressing glucagon-like peptide 1 receptor. Gene Ther 10:1712–1720PubMedCrossRefGoogle Scholar
  11. 11.
    Cheung AT, Dayanandan B, Lewis JT, et al. (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290:1959–1962PubMedCrossRefGoogle Scholar
  12. 12.
    Lu YC, Sternini C, Rozengurt E, et al. (2005) Release of transgenic human insulin from gastric G cells: a novel approach for the amelioration of diabetes. Endocrinology 146:2610–2619PubMedCrossRefGoogle Scholar
  13. 13.
    Grove JE, Bruscia E, Krause DS (2004) Plasticity of bone marrow-derived stem cells. Stem Cells 22:487–500PubMedCrossRefGoogle Scholar
  14. 14.
    Vats A, Bielby RC, Tolley NS, et al. (2005) Stem cells. Lancet 366:592–602PubMedCrossRefGoogle Scholar
  15. 15.
    Jorgensen C, Djouad F, Apparailly F, et al. (2003) Engineering mesenchymal stem cells for immunotherapy. Gene Ther 10:928–931PubMedCrossRefGoogle Scholar
  16. 16.
    Shah R, Jindal RM (2003) Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene. Pancreatology 3:422–428PubMedCrossRefGoogle Scholar
  17. 17.
    Gervaix A, Schwarz L, Law P, et al. (1997) Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther 8:2229–2238PubMedCrossRefGoogle Scholar
  18. 18.
    Kang J, Wither J, Hozumi N (1990) Long-term expression of a T-cell receptor beta-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci USA 87:9803–9807PubMedCrossRefGoogle Scholar
  19. 19.
    Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9–20PubMedCrossRefGoogle Scholar
  20. 20.
    Lu Y, Wang Z, Zhu M (2006) Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann Clin Lab Sci 36:127–136PubMedGoogle Scholar
  21. 21.
    Guo Z, Li H, Li X, et al. (2006) In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells 24:992–1000PubMedCrossRefGoogle Scholar
  22. 22.
    Sugiyama A, Hattori S, Tanaka S, et al. (1997) Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Horm Metab Res 29:599–603PubMedCrossRefGoogle Scholar
  23. 23.
    Hamada H, Kobune M, Nakamura K, et al. (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149–156PubMedCrossRefGoogle Scholar
  24. 24.
    Prockop DJ (2003) Further proof of the plasticity of adult stem cells and their role in tissue repair. J Cell Biol 160:807–809PubMedCrossRefGoogle Scholar
  25. 25.
    Jorgensen C, Djouad F, Apparailly F, et al. (2003) Engineering mesenchymal stem cells for immunotherapy. Gene Ther 10:928–931PubMedCrossRefGoogle Scholar
  26. 26.
    Urban SV, Kiss J, Vas V, et al. (2006) [Stem cell therapy for diabetes mellitus: progress, prospects and challenges]. Orv Hetil 147:791–797PubMedGoogle Scholar
  27. 27.
    Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346–358PubMedCrossRefGoogle Scholar
  28. 28.
    Tomanin R, Scarpa M (2004) Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. Curr Gene Ther 4:357–372PubMedGoogle Scholar
  29. 29.
    Wells DJ (2004) Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 11:1363–1369PubMedCrossRefGoogle Scholar
  30. 30.
    Plumas J, Chaperot L, Richard MJ, et al. (2005) Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19:1597–604PubMedCrossRefGoogle Scholar
  31. 31.
    Zappia E, Casazza S, Pedemonte E, et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755–1761PubMedCrossRefGoogle Scholar
  32. 32.
    Saito T, Kuang JQ, Bittira B, et al. (2002) Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74:19–24; discussion 24PubMedCrossRefGoogle Scholar
  33. 33.
    Fandrich F, Lin X, Chai GX, et al. (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171–178PubMedCrossRefGoogle Scholar
  34. 34.
    Harrington K, Alvarez-Vallina L, Crittendent NM, et al. (2002) Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery. J Hum Gene Ther 13:1263–1280CrossRefGoogle Scholar
  35. 35.
    Lee K, Majumdar MK, Buyaner D, et al. (2001) Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 3:857–866PubMedCrossRefGoogle Scholar
  36. 36.
    Kopen GC, Prockop DJ, Phinney DG (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96:10711–10716PubMedCrossRefGoogle Scholar
  37. 37.
    Gao Z, Golob J, Tanavde VM, et al. (2001) High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells 19:247–259PubMedCrossRefGoogle Scholar
  38. 38.
    Pannell D, Osborne CS, Yao S, et al. (2000) Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 19:5884–5894PubMedCrossRefGoogle Scholar
  39. 39.
    Hawley RG (2001) Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther 1:1–17PubMedCrossRefGoogle Scholar
  40. 40.
    Kan Z, Liu TJ (1999) Video microscopy of tumor metastasis: using the green fluorescent protein (GFP) gene as a cancer-cell-labeling system. Clin Exp Metastasis 17:49–55PubMedCrossRefGoogle Scholar
  41. 41.
    Lin Y, Chen X, Yan Z, et al. (2006) Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 285:69–78PubMedCrossRefGoogle Scholar
  42. 42.
    Kadowaki A, Tsukazaki T, Hirata K, et al. (2004) Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice. Bone 34:993–1003PubMedCrossRefGoogle Scholar
  43. 43.
    Ewing P, Wilke A, Brockhoff G, et al. (2003) Isolation and transplantation of allogeneic pulmonary endothelium derived from GFP transgenic mice. J Immunol Methods 283:307–315PubMedCrossRefGoogle Scholar
  44. 44.
    Deutsch G, Jung J, Zheng M, et al. (2001) A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128:871–881PubMedGoogle Scholar
  45. 45.
    Jung J, Zheng M, Goldfarb M, et al. (1999) Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284:1998–2003PubMedCrossRefGoogle Scholar
  46. 46.
    Rao MS, Dwivedi RS, Yeldandi AV, et al. (1989) Role of periductal and ductular epithelial cells of the adult rat pancreas in pancreatic hepatocyte lineage. A change in the differentiation commitment. Am J Pathol 134:1069–1086PubMedGoogle Scholar
  47. 47.
    Krakowski ML, Kritzik MR, Jones EM, et al. (1999) Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am J Pathol 154:683–691PubMedGoogle Scholar
  48. 48.
    Dabeva MD, Hwang SG, Vasa SR, et al. (1997) Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver. Proc Natl Acad Sci USA 94:7356–7361PubMedCrossRefGoogle Scholar
  49. 49.
    Wang X, Al-Dhalimy M, Lagasse E, et al. (2001) Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol 158:571–579PubMedGoogle Scholar
  50. 50.
    Suzuki A, Zheng YW, Kaneko S, et al. (2002) Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 156:173–184PubMedCrossRefGoogle Scholar
  51. 51.
    Lee HC, Kim SJ, Kim KS, et al. (2000) Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408:483–488PubMedCrossRefGoogle Scholar
  52. 52.
    Van Damme A, Chuah MK, Dell’accio F, et al. (2003) Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Haemophilia 9:94–103; Erratum. Haemophilia 2003;9:345PubMedCrossRefGoogle Scholar
  53. 53.
    Kintsurashvili E, Zhou D, Wheeler MB, et al. (1998) Genetic engineering of glucose-stimulated insulin secretion in Chinese hamster ovary cells. Artif Cells Blood Substit Immobil Biotechnol 26:329–40PubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2007

Authors and Affiliations

  • Jian Xu
    • 1
  • Yuhua Lu
    • 1
  • Fei Ding
    • 2
  • Xi Zhan
    • 3
  • Mingyan Zhu
    • 1
  • Zhiwei Wang
    • 1
  1. 1.Department of General Surgerythe Affiliated Hospital, Nantong UniversityNantongChina
  2. 2.Key Laboratory of NeuroregenerationNantong UniversityNantongChina
  3. 3.Greenebaum Cancer Center, School of MedicineUniversity of MarylandBaltimoreUSA

Personalised recommendations